Research / AVGO / Fundamental state Inspectable configuration
State dimensions Filing 0001730168-24-000023 General Corporate
Debt relative to revenue 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
614.23% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.02% · OPTIONAL · VALID
Operating cash generation 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
40.26% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.revenue
34.17% · CORE · VALID
Inventory pressure 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
16.05% · OPTIONAL · VALID
Gross margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
61.66% · CORE · VALID
Operating margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
17.41% · CORE · VALID
R&D intensity 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
19.30% · OPTIONAL · VALID
SBC intensity 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
13.23% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 9/9 normalized Level 3 Jan 30, 2022 9/9 normalized Level 3 May 1, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 30, 2022 9/9 normalized Level 3 Jan 29, 2023 9/9 normalized Level 3 Apr 30, 2023 9/9 normalized Level 3 Jul 30, 2023 9/9 normalized Level 3 Oct 29, 2023 9/9 normalized Level 3 Feb 4, 2024 9/9 normalized Level 3 May 5, 2024 9/9 normalized Level 3 Aug 4, 2024 9/9 normalized Level 3 Nov 3, 2024 9/9 normalized Level 3 Feb 2, 2025 9/9 normalized Level 3 May 4, 2025 9/9 normalized Level 3 Aug 3, 2025 9/9 normalized Level 3 Nov 2, 2025 9/9 normalized Level 3 Feb 1, 2026 9/9 normalized Level 3 May 3, 2026 9/9 normalized Level 3 Aug 2, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 105.03%
Current 614.23%
Delta 509.20% Capex Intensity Decreased
Previous 1.26%
Current 1.02%
Delta -0.24% Cash Generation Decreased
Previous 50.49%
Current 40.26%
Delta -10.23% Growth Increased
Previous 7.88%
Current 34.17%
Delta 26.29% Inventory Pressure Increased
Previous 5.30%
Current 16.05%
Delta 10.75% Margin Decreased
Previous 68.93%
Current 61.66%
Delta -7.27% Profitability Decreased
Previous 45.25%
Current 17.41%
Delta -27.83% R And D Intensity Increased
Previous 14.67%
Current 19.30%
Delta 4.63% Sbc Intensity Increased
Previous 6.06%
Current 13.23%
Delta 7.17% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.